SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 65 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 4,012,903 | $15,168,773 | 7.77% |
| Nextech Invest Ltd. | 1,910,029 | $7,219,910 | 2.19% |
| K2 PRINCIPAL FUND, L.P. | 2,552,062 | $9,646,794 | 2.02% |
| Charles Schwab Trust Co | 4,246,071 | $16,050,148 | 1.81% |
| Sio Capital Management, LLC | 1,105,911 | $4,180,344 | 1.29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,077,927 | $41,874,564 | 0.92% |
| SECTORAL ASSET MANAGEMENT INC | 1,049,191 | $3,965,942 | 0.77% |
| Orbimed Advisors | 9,240,887 | $34,930,553 | 0.74% |
| RA Capital Management | 9,459,678 | $35,757,583 | 0.70% |
| K2 PRINCIPAL FUND, L.P. | 688,900 | $2,604,042 | 0.55% |